S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Here's something only a handful of people know (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Here's something only a handful of people know (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Here's something only a handful of people know (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Here's something only a handful of people know (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Here's something only a handful of people know (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Here's something only a handful of people know (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Here's something only a handful of people know (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Here's something only a handful of people know (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Here's something only a handful of people know (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Here's something only a handful of people know (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Here's something only a handful of people know (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Here's something only a handful of people know (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
NASDAQ:PACB

Pacific Biosciences of California (PACB) Stock Forecast, Price & News

$12.48
+0.51 (+4.26%)
(As of 05/26/2023 ET)
Compare
Today's Range
$12.03
$12.89
50-Day Range
$8.36
$13.06
52-Week Range
$3.85
$14.20
Volume
3.72 million shs
Average Volume
3.75 million shs
Market Capitalization
$3.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.75

Pacific Biosciences of California MarketRank™ Forecast

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
2.2% Upside
$12.75 Price Target
Short Interest
Bearish
9.68% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.14mentions of Pacific Biosciences of California in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$180,019 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.24) to ($1.06) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.36 out of 5 stars

Medical Sector

985th out of 1,018 stocks

Analytical Instruments Industry

27th out of 29 stocks


PACB stock logo

About Pacific Biosciences of California (NASDAQ:PACB) Stock

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Receive PACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacific Biosciences of California and its competitors with MarketBeat's FREE daily newsletter.

PACB Stock News Headlines

"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Piper Sandler Remains a Hold on Pacific Biosciences (PACB)
"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Expert Ratings for Pacific Biosciences
Pacific Biosciences of California, Inc. Q1 Loss misses estimates
Assessing Pacific Biosciences And Their Revio Launch
See More Headlines
Receive PACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacific Biosciences of California and its competitors with MarketBeat's FREE daily newsletter.

PACB Company Calendar

Last Earnings
5/02/2023
Today
5/27/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Sector
Medical
Current Symbol
NASDAQ:PACB
CUSIP
69404D10
Employees
728
Year Founded
2004

Price Target and Rating

Average Stock Price Forecast
$12.75
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+2.2%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$-314,250,000.00
Net Margins
-239.32%
Pretax Margin
-239.32%

Debt

Sales & Book Value

Annual Sales
$128.30 million
Book Value
$2.77 per share

Miscellaneous

Free Float
245,143,000
Market Cap
$3.12 billion
Optionable
Optionable
Beta
1.67

Social Links


Key Executives

  • Christian O. HenryChristian O. Henry
    President, Chief Executive Officer & Director
  • Mark David van Oene
    Chief Operating Officer
  • Susan G. KimSusan G. Kim
    Chief Financial Officer
  • Stephen W. Turner
    Chief Technology Officer
  • Jonas Korlach
    Chief Scientific Officer













PACB Stock - Frequently Asked Questions

Should I buy or sell Pacific Biosciences of California stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PACB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PACB, but not buy additional shares or sell existing shares.
View PACB analyst ratings
or view top-rated stocks.

What is Pacific Biosciences of California's stock price forecast for 2023?

7 Wall Street research analysts have issued 1-year price targets for Pacific Biosciences of California's shares. Their PACB share price forecasts range from $8.00 to $15.00. On average, they predict the company's share price to reach $12.75 in the next twelve months. This suggests a possible upside of 2.2% from the stock's current price.
View analysts price targets for PACB
or view top-rated stocks among Wall Street analysts.

How have PACB shares performed in 2023?

Pacific Biosciences of California's stock was trading at $8.18 on January 1st, 2023. Since then, PACB shares have increased by 52.6% and is now trading at $12.48.
View the best growth stocks for 2023 here
.

When is Pacific Biosciences of California's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our PACB earnings forecast
.

How were Pacific Biosciences of California's earnings last quarter?

Pacific Biosciences of California, Inc. (NASDAQ:PACB) released its earnings results on Tuesday, May, 2nd. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.33) by $0.02. The biotechnology company earned $38.90 million during the quarter, compared to analyst estimates of $34.38 million. Pacific Biosciences of California had a negative trailing twelve-month return on equity of 47.46% and a negative net margin of 239.32%. Pacific Biosciences of California's revenue for the quarter was up 17.3% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.37) earnings per share.

What is Christian Henry's approval rating as Pacific Biosciences of California's CEO?

2 employees have rated Pacific Biosciences of California Chief Executive Officer Christian Henry on Glassdoor.com. Christian Henry has an approval rating of 100% among the company's employees. This puts Christian Henry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pacific Biosciences of California own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pacific Biosciences of California investors own include Pfizer (PFE), Gilead Sciences (GILD), Illumina (ILMN), Novavax (NVAX), Advanced Micro Devices (AMD), AT&T (T), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Invitae (NVTA) and Tesla (TSLA).

What is Pacific Biosciences of California's stock symbol?

Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB."

Who are Pacific Biosciences of California's major shareholders?

Pacific Biosciences of California's stock is owned by a number of retail and institutional investors. Top institutional investors include ARK Investment Management LLC (11.20%), BlackRock Inc. (8.08%), Sumitomo Mitsui Trust Holdings Inc. (5.61%), Nikko Asset Management Americas Inc. (5.61%), Jackson Square Partners LLC (4.84%) and Farallon Capital Management LLC (2.54%). Insiders that own company stock include Christian O Henry, Eric Schaefer, Kathy Ordonez, Lucy Shapiro, Michael Hunkapiller, Michele Farmer, Oene Mark Van, Peter Fromen, Susan G Kim and William W Ericson.
View institutional ownership trends
.

How do I buy shares of Pacific Biosciences of California?

Shares of PACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pacific Biosciences of California's stock price today?

One share of PACB stock can currently be purchased for approximately $12.48.

How much money does Pacific Biosciences of California make?

Pacific Biosciences of California (NASDAQ:PACB) has a market capitalization of $3.12 billion and generates $128.30 million in revenue each year. The biotechnology company earns $-314,250,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis.

How many employees does Pacific Biosciences of California have?

The company employs 728 workers across the globe.

Does Pacific Biosciences of California have any subsidiaries?
The following companies are subsidiares of Pacific Biosciences of California: Circulomics, Omniome, PacBio Singapore PTE Limited, Pacific Biosciences (Shanghai) Co. Ltd., Pacific Biosciences Canada Limited, Pacific Biosciences Germany GmbH, Pacific Biosciences International LLC, Pacific Biosciences Japan GK, and Pacific Biosciences UK Limited.
Read More
How can I contact Pacific Biosciences of California?

Pacific Biosciences of California's mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. The official website for the company is www.pacb.com. The biotechnology company can be reached via phone at (650) 521-8000, via email at ir@pacb.com, or via fax at 302-636-5454.

This page (NASDAQ:PACB) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -